August 15, 2012 10:23 ET

Active Stocks to Watch - PZOO, ARNA, IFLM, JDSU

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by

CORAL SPRINGS, FL--(Marketwire - Aug 15, 2012) - "stocks to watch" for today: Pazoo, Inc. (OTCBB: PZOO), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Independent Film Development Corporation (OTCBB: IFLM), JDS Uniphase Corp. (NASDAQ: JDSU)

Research Alert issued for PZOO as PAZOO, INC sets to launch a massive National TV and Awareness Campaign. Pazoo intends to run approximately 70,000 sixty-second local advertising spots during the months of September and October.

Headline News: Set To Launch First National TV Advertising Campaign. Pazoo, Inc., the #1 online health and wellness social community for people and their pets -- has completed production of its first national TV ad campaign which includes three 60-second commercials.

This branding campaign is designed to build awareness and drive traffic to, which was launched by PAZOO, INC. earlier this year. Each of the campaign's three commercials highlights a difference for health-conscious consumers who own pets and want to be as healthy as they can be: One spot brands and establishes as the #1 online health and wellness social community for people and pets. Another introduces the site's team of experts in various health and wellness fields who provide simple information consumers can utilize in achieving fuller and richer lives for both themselves and their pets. The third spot showcases one of the site's unique selection of products: Vita-Stim™ Mega Multivitamins & Minerals -- the first and only daily adult "multi" with regenerative stem cell nutrition support.

For more details and to read the entire press release issued by PZOO that includes the full company disclosures please go to

Or watch the video press release at

Also be sure to get more comprehensive details on Pazoo, Inc. by viewing an Overview Report issued by Harbinger Research, an Independent Investment Analysis Firm, released on August 1st, 2012:

Don't miss out on future alerts of this emerging company, sign up for our free News Alerts now at

Get an edge on the market with our Premium News Alerts that are FREE for a limited time at
Follow us on Facebook: and Twitter:

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) adds to sharp gains from yesterday as LifeSci Advisors publishes an upbeat note about the stock. LifeSci's main points include Arena possibly receiving a $1.2B one-time purchase price adjustment from its partner Eisai based on net sales of diet drug Belviq.

Independent Film Development Corporation (OTCBB: IFLM) announced that it signed an agreement to produce the upcoming feature film, "Famine". IFLM has also been awarded the exclusive worldwide sales rights. Pre-production is scheduled to begin in November 2012

JDS Uniphase Corp. (NASDAQ: JDSU) reported results for its fourth fiscal quarter and year ended June 30, 2012. On a GAAP basis, net revenue for the fourth fiscal quarter of 2012 was $439.3 million and net loss was $(24.3) million, or $(0.10) per share. This compares to net revenue of $409.2 million and net loss of $(17.4) million, or $ (0.08) per share for the prior quarter, and net revenue of $471.8 million and net income of $9.3 million, or $0.04 per share for the fourth fiscal quarter of 2011.

If you're a company interested in having FN Media Group assist you with creating a greater awareness for your next news release utilizing our multi-media and leading edge outreach solutions, contact us now at

DISCLAIMER: FN Media Group LLC (FNMG) owns and operates (FNM) which disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For disseminating this release, FNMG was compensated seven hundred fifty dollars for this news release on behalf of Pazoo, Inc. (OTCBB: PZOO). FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. 

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information